Real estate investment trusts sit at the intersection of income generation and interest-rate sensitivity, making them a focal point for investors navigating today's monetary-policy backdrop. NURE and USRT are both passively managed U.S. REIT ETFs, yet they occupy very different niches within the same asset class. NURE is a thematic fund that isolates REITs with short-term lease structures, while USRT is a broad core fund spanning the full equity REIT market. For investors deciding between concentrated tactical exposure and diversified core positioning, this ETF comparison clarifies the structural trade-offs that drive relative performance.
NURE tracks the Dow Jones U.S. Select Short-Term REIT Index, a float-adjusted, market-cap-weighted subset of U.S. REITs whose property types generate cash flows from shorter-duration leases. This design deliberately reduces interest-rate sensitivity relative to traditional long-lease REITs. The fund is passively managed and rebalances with a roughly 5% cap per holding, limiting single-name concentration.
The portfolio holds approximately 30 securities concentrated in apartments, self-storage, hotels, and manufactured housing. Top holdings have included HST, RHP, EXR, PSA, SUI, CUBE, ESS, UDR, ELS, and AMH, with the top ten accounting for roughly half of assets. The fund charges a 0.35% expense ratio and is a relatively small product with limited average daily volume, making it a less liquid vehicle than its broad-market peers.
USRT seeks to track the FTSE Nareit Equity REITs 40 Act Capped Index, a broad, market-cap-weighted benchmark of U.S.-listed equity REITs that excludes mortgage, infrastructure, and timber REITs. The fund is passively managed and generally invests at least 80% of assets in index constituents, offering diversified, low-cost core real estate exposure.
The portfolio holds roughly 126 securities spanning specialized, healthcare, retail, residential, industrial, office, and hotel REITs. Top holdings have included WELL, PLD, EQIX, SPG, DLR, PSA, O, VMRK, VTR, and IRM. With a 0.08% expense ratio, billions in assets under management, and substantial daily trading volume, USRT is among the most cost-efficient and liquid ways to own broad U.S. REIT exposure.
Both funds operate within the U.S. REIT sector, whose performance is closely tied to interest-rate expectations, credit conditions, and property-level fundamentals. Rate-sensitive property types — including apartments, hotels, and self-storage that anchor NURE — tend to reprice rents quickly, which can support income during inflationary periods but also increases cyclicality. By contrast, USRT's broader mix includes structural-growth segments such as data centers, towers, and healthcare real estate that are less directly tied to the short end of the yield curve. Sector rotation between growth-oriented and yield-oriented REITs, along with earnings cycles among the largest holdings, has been a recurring driver of relative positioning in recent market cycles.
Over recent weeks and months, the two funds have diverged in ways consistent with their construction. NURE's concentrated short-lease exposure makes it more sensitive to near-term shifts in lodging demand, apartment rent growth, and storage fundamentals, translating into higher volatility and sharper drawdowns historically. USRT, with its diversified and large-cap tilt, has generally offered a smoother return profile and broader participation across healthcare, industrial, and specialized REITs. In fund performance terms, USRT's lower fee drag and deeper liquidity reinforce its appeal as a core holding, while NURE behaves more like a tactical expression of a specific rate and lease-duration view.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending names, breakout candidates, and market opportunities far more efficiently than manual screening. Explore the AI Screener to streamline your research process.
Based on observable structural factors, Tickeron's AI currently favors USRT. The fund's materially lower expense ratio, broader diversification across more than 120 holdings, larger asset base, and deeper liquidity provide durable advantages in relative positioning. While NURE offers a legitimate thematic tilt toward short-duration property types, its concentration, higher cost, and thinner trading volume introduce greater idiosyncratic and structural risk. Absent a specific, high-conviction rate or lease-duration view, the AI's probabilistic assessment tilts toward USRT as the more balanced and cost-efficient vehicle for broad REIT sector exposure.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The 10-day RSI Indicator for USRT moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In 21 of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at 88%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 56 of 68 cases where USRT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 82%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on USRT as a result. In 67 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
The Moving Average Convergence Divergence Histogram (MACD) for USRT turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 38 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 84%.
The 50-day moving average for USRT moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where USRT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
USRT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
USRT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for USRT crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +2.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where USRT advanced for three days, in 261 of 312 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Aroon Indicator entered an Uptrend today. In 250 of 310 cases where USRT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
| NURE | USRT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 80% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 82% |
| Advances ODDS (%) | 4 days ago 80% | 16 days ago 84% |
| Declines ODDS (%) | 8 days ago 84% | 3 days ago 82% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 84% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 81% |
A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
|---|---|---|---|---|
| NURE | 100% | +0.03% | ||
| UDR - NURE | 83% Closely correlated | +0.03% | ||
| MAA - NURE | 82% Closely correlated | -0.68% | ||
| CPT - NURE | 80% Closely correlated | -0.32% | ||
| ESS - NURE | 76% Closely correlated | +1.06% | ||
| VMRK - NURE | 75% Closely correlated | -0.78% | ||
More | ||||
A.I.dvisor indicates that over the last year, USRT has been closely correlated with KIM. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if USRT jumps, then KIM could also see price increases.
| Ticker / NAME | Correlation To USRT | 1D Price Change % | ||
|---|---|---|---|---|
| USRT | 100% | +0.34% | ||
| KIM - USRT | 80% Closely correlated | +0.23% | ||
| O - USRT | 77% Closely correlated | +0.41% | ||
| BRX - USRT | 77% Closely correlated | +1.66% | ||
| PLD - USRT | 76% Closely correlated | -0.27% | ||
| CUBE - USRT | 75% Closely correlated | +0.38% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CHPX | 75.99 | 0.43 | +0.57% |
| Global X AI Semiconductor & Quantum ETF (CHPX) | |||
| HEQQ | 58.68 | 0.16 | +0.28% |
| JPMorgan Nasdaq Hedged Equity Laddered Overlay ETF (HEQQ) | |||
| BNDW | 66.47 | 0.07 | +0.11% |
| Vanguard Total World Bond ETF (BNDW) | |||
| EVSB | 50.71 | -0.01 | -0.01% |
| Eaton Vance Ultra-Short Income ETF (EVSB) | |||
| APLZ | 42.28 | -1.65 | -3.76% |
| Tradr 2X Short APLD Daily ETF (APLZ) | |||